BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 27391860)

  • 1. Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study.
    Greer MD; Brown AM; Shih JH; Summers RM; Marko J; Law YM; Sankineni S; George AK; Merino MJ; Pinto PA; Choyke PL; Turkbey B
    J Magn Reson Imaging; 2017 Feb; 45(2):579-585. PubMed ID: 27391860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All over the map: An interobserver agreement study of tumor location based on the PI-RADSv2 sector map.
    Greer MD; Shih JH; Barrett T; Bednarova S; Kabakus I; Law YM; Shebel H; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
    J Magn Reson Imaging; 2018 Aug; 48(2):482-490. PubMed ID: 29341356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).
    Gaur S; Harmon S; Gupta RT; Margolis DJ; Lay N; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
    Acad Radiol; 2019 Jan; 26(1):5-14. PubMed ID: 29705281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interreader agreement of PI-RADS v. 2 in assessing prostate cancer with multiparametric MRI: A study using whole-mount histology as the standard of reference.
    Girometti R; Giannarini G; Greco F; Isola M; Cereser L; Como G; Sioletic S; Pizzolitto S; Crestani A; Ficarra V; Zuiani C
    J Magn Reson Imaging; 2019 Feb; 49(2):546-555. PubMed ID: 30187600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided diagnosis prior to conventional interpretation of prostate mpMRI: an international multi-reader study.
    Greer MD; Lay N; Shih JH; Barrett T; Bittencourt LK; Borofsky S; Kabakus I; Law YM; Marko J; Shebel H; Mertan FV; Merino MJ; Wood BJ; Pinto PA; Summers RM; Choyke PL; Turkbey B
    Eur Radiol; 2018 Oct; 28(10):4407-4417. PubMed ID: 29651763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists.
    Sonn GA; Fan RE; Ghanouni P; Wang NN; Brooks JD; Loening AM; Daniel BL; To'o KJ; Thong AE; Leppert JT
    Eur Urol Focus; 2019 Jul; 5(4):592-599. PubMed ID: 29226826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of the accuracy of multi-parametric MRI prostate in detecting prostate cancer within a local reporting service.
    Tsai WC; Field L; Stewart S; Schultz M
    J Med Imaging Radiat Oncol; 2020 Jun; 64(3):379-384. PubMed ID: 32243728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histology core-specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate.
    Kuru TH; Roethke MC; Rieker P; Roth W; Fenchel M; Hohenfellner M; Schlemmer HP; Hadaschik BA
    BJU Int; 2013 Dec; 112(8):1080-7. PubMed ID: 23937255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of prostate cancer with multiparametric MRI (mpMRI): effect of dedicated reader education on accuracy and confidence of index and anterior cancer diagnosis.
    Garcia-Reyes K; Passoni NM; Palmeri ML; Kauffman CR; Choudhury KR; Polascik TJ; Gupta RT
    Abdom Imaging; 2015 Jan; 40(1):134-42. PubMed ID: 25034558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric MRI for the detection of local recurrence of prostate cancer in the setting of biochemical recurrence after low dose rate brachytherapy.
    Valle LF; Greer MD; Shih JH; Barrett T; Law YM; Rosenkrantz AB; Shebel H; Muthigi A; Su D; Merino MJ; Wood BJ; Pinto PA; Krauze AV; Kaushal A; Choyke PL; Türkbey B; Citrin DE
    Diagn Interv Radiol; 2018; 24(1):46-53. PubMed ID: 29317377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer detection with biparametric magnetic resonance imaging (bpMRI) by readers with different experience: performance and comparison with multiparametric (mpMRI).
    Gatti M; Faletti R; Calleris G; Giglio J; Berzovini C; Gentile F; Marra G; Misischi F; Molinaro L; Bergamasco L; Gontero P; Papotti M; Fonio P
    Abdom Radiol (NY); 2019 May; 44(5):1883-1893. PubMed ID: 30788558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.
    Schaudinn A; Gawlitza J; Mucha S; Linder N; Franz T; Horn LC; Kahn T; Busse H
    Eur J Radiol; 2019 Jul; 116():180-185. PubMed ID: 31153562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy of
    Scheltema MJ; Chang JI; Stricker PD; van Leeuwen PJ; Nguyen QA; Ho B; Delprado W; Lee J; Thompson JE; Cusick T; Spriensma AS; Siriwardana AR; Yuen C; Kooner R; Hruby G; O'Neill G; Emmett L
    BJU Int; 2019 Nov; 124 Suppl 1():42-49. PubMed ID: 31287613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1.
    Brembilla G; Dell'Oglio P; Stabile A; Damascelli A; Brunetti L; Ravelli S; Cristel G; Schiani E; Venturini E; Grippaldi D; Mendola V; Rancoita PMV; Esposito A; Briganti A; Montorsi F; Del Maschio A; De Cobelli F
    Eur Radiol; 2020 Jun; 30(6):3383-3392. PubMed ID: 32052171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA.
    De Visschere P; Lumen N; Ost P; Decaestecker K; Pattyn E; Villeirs G
    Clin Radiol; 2017 Jan; 72(1):23-32. PubMed ID: 27726850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility of Index Lesion Size and Mean Apparent Diffusion Coefficient Values Measured by Prostate Multiparametric MRI: Correlation With Whole-Mount Sectioning of Specimens.
    Diaz de Leon A; Leyendecker JR; Otero-Muinelo S; Grewal H; Xi Y; Francis F; Pedrosa I; Costa DN
    AJR Am J Roentgenol; 2018 Oct; 211(4):783-788. PubMed ID: 30160988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Prostate Imaging Reporting and Data System Version 2 (PI-RADS v2): Interobserver Agreement and Positive Predictive Value for Localization of Intermediate- and High-Grade Prostate Cancers on Multiparametric Magnetic Resonance Imaging.
    Chen F; Cen S; Palmer S
    Acad Radiol; 2017 Sep; 24(9):1101-1106. PubMed ID: 28546032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3T multiparametric MR imaging, PIRADSv2-based detection of index prostate cancer lesions in the transition zone and the peripheral zone using whole mount histopathology as reference standard.
    Asvadi NH; Afshari Mirak S; Mohammadian Bajgiran A; Khoshnoodi P; Wibulpolprasert P; Margolis D; Sisk A; Reiter RE; Raman SS
    Abdom Radiol (NY); 2018 Nov; 43(11):3117-3124. PubMed ID: 29725743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.